(Q40394844)

20 September 2017

title

Diagnostic and prognostic values of tissue hsa-miR-30c and hsa-miR-203 in prostate carcinoma (English)

1 reference

20 September 2017

Ziling Huang

1

1 reference

20 September 2017

Long Zhang

series ordinal

2

1 reference

20 September 2017

Xianghua Yi

series ordinal

3

1 reference

20 September 2017

Xiaoting Yu

series ordinal

4

1 reference

20 September 2017

publication date

24 October 2015

1 reference

20 September 2017

1 reference

20 September 2017

volume

37

1 reference

20 September 2017

issue

4

1 reference

20 September 2017

page(s)

4359-4365

1 reference

Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

Identification of miR-187 and miR-182 as biomarkers of early diagnosis and prognosis in patients with prostate cancer treated with radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

MicroRNA-335 acts as a candidate tumor suppressor in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

Molecular sampling of prostate cancer: a dilemma for predicting disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

Downregulation and prognostic performance of microRNA 224 expression in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

Potential Urinary miRNA Biomarker Candidates for the Accurate Detection of Prostate Cancer among Benign Prostatic Hyperplasia Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

miRNAs as biomarkers in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

MiR-215 modulates gastric cancer cell proliferation by targeting RB1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

Micro-RNA profiling in kidney and bladder cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

Detection of cancer with serum miRNAs on an oligonucleotide microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

Diet, microRNAs and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

MicroRNA-23b downregulates peroxiredoxin III in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

Rewiring of an epithelial differentiation factor, miR-203, to inhibit human squamous cell carcinoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

Analysis of microRNA-203 function in CREB/MITF/RAB27a pathway: comparison between canine and human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

Involvement of miR-30c in resistance to doxorubicin by regulating YWHAZ in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

SUMOylation of pontin chromatin-remodeling complex reveals a signal integration code in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

Characterization of KRAS rearrangements in metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

MicroRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4262-9

Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer

21 January 2018

1 reference

12 December 2020

Review of the literature: PCA3 for prostate cancer risk assessment and prognostication.

1 reference

12 December 2020

Epithelial and stromal expression of miRNAs during prostate cancer progression

1 reference

12 December 2020

Serum microRNA-92 expression in patients with ovarian epithelial carcinoma

1 reference

12 December 2020

Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy

1 reference

12 December 2020

Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis

1 reference

12 December 2020

Circulating MicroRNAs as Biomarkers for Hepatocellular Carcinoma

1 reference

12 December 2020

The value of a single biopsy with 12 transperineal cores for detecting prostate cancer in patients with elevated prostate specific antigen

1 reference

12 December 2020

A comparative study of prostate cancer detection and management in China and in France.

1 reference

12 December 2020

Akt mediates metastasis-associated gene 1 (MTA1) regulating the expression of E-cadherin and promoting the invasiveness of prostate cancer cells

1 reference

12 December 2020

Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

1 reference

12 December 2020

MicroRNA-30c serves as an independent biochemical recurrence predictor and potential tumor suppressor for prostate cancer

1 reference

12 December 2020

Robustness of free prostate specific antigen measurements to reduce unnecessary biopsies in the 2.6 to 4.0 ng./ml. range

1 reference

12 December 2020

miR-203 is a direct transcriptional target of E2F1 and causes G1 arrest in esophageal cancer cells

1 reference

12 December 2020

Estrogen regulates the tumour suppressor MiRNA-30c and its target gene, MTA-1, in endometrial cancer

1 reference

12 December 2020

10.1007/S13277-015-4262-9

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

1039236370

0 references

1 reference